Cargando…

Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice

Premature ovarian insufficiency (POI) is a significant complication of cytotoxic treatments due to extreme ovarian sensitivity to chemotherapy and radiation. POI is particularly devastating for young girls reaching puberty, because it irreversibly affects their physical and cognitive development. Ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Day, James Ronald, David, Anu, Barbosa, Mayara Garcia de Mattos, Brunette, Margaret Ann, Cascalho, Marilia, Shikanov, Ariella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851353/
https://www.ncbi.nlm.nih.gov/pubmed/31719632
http://dx.doi.org/10.1038/s41598-019-53075-8
_version_ 1783469616676208640
author Day, James Ronald
David, Anu
Barbosa, Mayara Garcia de Mattos
Brunette, Margaret Ann
Cascalho, Marilia
Shikanov, Ariella
author_facet Day, James Ronald
David, Anu
Barbosa, Mayara Garcia de Mattos
Brunette, Margaret Ann
Cascalho, Marilia
Shikanov, Ariella
author_sort Day, James Ronald
collection PubMed
description Premature ovarian insufficiency (POI) is a significant complication of cytotoxic treatments due to extreme ovarian sensitivity to chemotherapy and radiation. POI is particularly devastating for young girls reaching puberty, because it irreversibly affects their physical and cognitive development. Changes occurring during puberty determine their height, bone health, insulin responsiveness, lipid metabolism, cardiovascular health and cognition. The only available treatment for POI during puberty is hormone replacement therapy (HRT), which delivers non-physiological levels of estrogen, lacks other ovarian hormones and pulsatility, and is not responsive to feedback regulation. Here we report that ovarian allografts encapsulated in a hydrogel-based capsule and implanted in ovariectomized mice restore ovarian endocrine function in immune competent mice. Ovarian tissue from BALB/c mice was encapsulated in poly(ethylene-glycol) (PEG) hydrogels, with a proteolytically degradable core and a non-degradable shell. The dual capsules were implanted subcutaneously in immune competent ovariectomized C57BL/6 mice for a period of 60 days. As expected, non-encapsulated ovarian allografts implanted in a control group sensitized the recipients as confirmed with donor-specific IgG in the serum, which increased 26-fold in the 3 weeks following transplantation (p = 0.02) and infiltration of the graft with CD8 T cells consistent with allo-immunity. In contrast, encapsulation in the Dual PEG capsules prevented sensitization to the allograft in all the recipients with no evidence of lymphocytic infiltration. In summary, the approach of hydrogel-based immunoisolation presents a minimally invasive and robust cell-therapy to restore hormonal balance in ovarian insufficiency. This report is the first to demonstrate the application of a tunable PEG-based hydrogel as an immunoisolator of allogeneic ovarian tissue to restore endocrine function in ovariectomized mice and prevent cell-mediated immune rejection in immune competent mice.
format Online
Article
Text
id pubmed-6851353
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68513532019-11-19 Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice Day, James Ronald David, Anu Barbosa, Mayara Garcia de Mattos Brunette, Margaret Ann Cascalho, Marilia Shikanov, Ariella Sci Rep Article Premature ovarian insufficiency (POI) is a significant complication of cytotoxic treatments due to extreme ovarian sensitivity to chemotherapy and radiation. POI is particularly devastating for young girls reaching puberty, because it irreversibly affects their physical and cognitive development. Changes occurring during puberty determine their height, bone health, insulin responsiveness, lipid metabolism, cardiovascular health and cognition. The only available treatment for POI during puberty is hormone replacement therapy (HRT), which delivers non-physiological levels of estrogen, lacks other ovarian hormones and pulsatility, and is not responsive to feedback regulation. Here we report that ovarian allografts encapsulated in a hydrogel-based capsule and implanted in ovariectomized mice restore ovarian endocrine function in immune competent mice. Ovarian tissue from BALB/c mice was encapsulated in poly(ethylene-glycol) (PEG) hydrogels, with a proteolytically degradable core and a non-degradable shell. The dual capsules were implanted subcutaneously in immune competent ovariectomized C57BL/6 mice for a period of 60 days. As expected, non-encapsulated ovarian allografts implanted in a control group sensitized the recipients as confirmed with donor-specific IgG in the serum, which increased 26-fold in the 3 weeks following transplantation (p = 0.02) and infiltration of the graft with CD8 T cells consistent with allo-immunity. In contrast, encapsulation in the Dual PEG capsules prevented sensitization to the allograft in all the recipients with no evidence of lymphocytic infiltration. In summary, the approach of hydrogel-based immunoisolation presents a minimally invasive and robust cell-therapy to restore hormonal balance in ovarian insufficiency. This report is the first to demonstrate the application of a tunable PEG-based hydrogel as an immunoisolator of allogeneic ovarian tissue to restore endocrine function in ovariectomized mice and prevent cell-mediated immune rejection in immune competent mice. Nature Publishing Group UK 2019-11-12 /pmc/articles/PMC6851353/ /pubmed/31719632 http://dx.doi.org/10.1038/s41598-019-53075-8 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Day, James Ronald
David, Anu
Barbosa, Mayara Garcia de Mattos
Brunette, Margaret Ann
Cascalho, Marilia
Shikanov, Ariella
Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title_full Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title_fullStr Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title_full_unstemmed Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title_short Encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
title_sort encapsulation of ovarian allograft precludes immune rejection and promotes restoration of endocrine function in immune-competent ovariectomized mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851353/
https://www.ncbi.nlm.nih.gov/pubmed/31719632
http://dx.doi.org/10.1038/s41598-019-53075-8
work_keys_str_mv AT dayjamesronald encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice
AT davidanu encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice
AT barbosamayaragarciademattos encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice
AT brunettemargaretann encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice
AT cascalhomarilia encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice
AT shikanovariella encapsulationofovarianallograftprecludesimmunerejectionandpromotesrestorationofendocrinefunctioninimmunecompetentovariectomizedmice